Endoscopic ultrasound-guided choledoco-duodenostomy as an alternative to percutaneous trans-hepatic cholangiography  by Nicholson, James A. et al.
TECHNICAL REPORT
Endoscopic ultrasound-guided choledoco-duodenostomy as an
alternative to percutaneous trans-hepatic cholangiography
James A. Nicholson1, Marianne Johnstone1, Michael G. T. Raraty2 & Jonathan C. Evans3
1NIHR Pancreas Biomedical Research Unit, 2Department of Surgery, and 3Department of Radiology, Ground Floor, Royal Liverpool University Hospital,
Liverpool, UK
Abstracthpb_480 483..486
Background: Endoscopic ultrasonography (EUS)-guided choledochoduodenostomy (CDS) is an alter-
native to percutaneous transhepatic cholangiography (PTC) drainage in patients with an obstructed biliary
system where conventional endoscopic retrograde biliary drainage (ERBD) has been unsuccessful.
Methods: Five EUS-CDS procedures were reviewed to assess whether successful decompression was
achieved and maintained.
Results: There was technical success in each instance with no immediate complications. There was a
significant fall in the median bilirubin of 164 mmol/l. The median follow-up was 44 days. In one patient the
stent migrated with no adverse outcome.
Conclusion: EUS-CDS is a viable alternative to PTC with fewer complications and comparable success
rates. EUS-CDS may offer a future route for novel therapeutic advances.
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Introduction
First described by Giovannini and colleagues in 2001, endo-
scopic ultrasound-guided choledoco-duodenostomy (EUS-CDS)
is increasingly being used globally as an alternative to percutane-
ous trans-hepatic cholangiography (PTC) in patients where ana-
tomical abnormality has rendered endoscopic transpapillary
insertion of a biliary stent impossible.1 Peri-hepatic ascites is the
only relative contraindication to PTC,2 but PTC does carry a sig-
nificant associated morbidity and mortality.3 In addition, PTC
normally requires a separate procedure after failed ERCP biliary
drainage, thereby increasing the morbidity associated with biliary
stasis. In spite of interest internationally there are few published
examples of EUS-CDS.
Endoscopic retrograde biliary drainage (ERBD) remains the
most popular choice of biliary decompression in those patients
with obstruction of the distal main bile duct. The success of this
technique ranges from 90% to 95% in the USA.2 Failure may be as
a consequence of: variations in anatomy; the presenting pathology
(impacted stones, tumour infiltration and duodenal compression
by pancreatic pseudocyst); previous surgery; or may be a variant
of normal anatomy (periampullary diverticula and tortuous
ducts).
The authors’ institution performs over 500 upper gastrointes-
tinal endoluminal interventional procedures annually. Previously
a failed ERBD would lead to repeated attempts, PTC or operative
intervention. The aim of the present study was to describe the
technical factors and outcome associated with an alternative
method of obtaining biliary drainage after failed ERBD.
Methods
Five consecutive patients who had undergone EUS-CDS, per-
formed by one of the authors (J.C.E.) over a 6-month period, were
reviewed.
Patients within this cohort were deemed suitable for an
attempted EUS-CDS as a one-stage procedure after a further
ERBD attempt, rather than being recalled for PTC. All patients
had undergone at least one unsuccessful ERBD attempt. Patients
were consented for EUS-CDS before a repeat ERCP. Once
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cannulation of the papilla had proven to be unsuccessful, a routine
EUS examination of the biliary tree was performed as follows.
A linear echoendoscope (Olympus© GFUE260; Olympus Life
Science, Hamburg, Germany) is placed within the first part of the
duodenum using a ‘long scope’ position. The optimal position has
the tip of the endoscope in a vertical orientation when seen on
fluoroscopy. This results in a longitudinal view of the lower
common bile duct (Fig. 1), and optimizes a vertical approach into
the bile duct. The duct is assessed for accessibility (distance from
the duodenal wall and evidence of intervening vessels) before
puncturing the duct directly above the common bile duct (CBD)
stricture. A 19-gauge fine-needle aspiration needle (Cook©
EchoTip Ultra™; CookMedical, Bloomington, IN,USA) is used to
puncture the duct using ultrasound guidance. The puncture needs
to be as closely aligned to the duct as possible to allow easy passage
of the wire and stent.
Once the tip of the 19-G needle is within the duct, bile is
aspirated for confirmation of position, followed by contrast
injection (Fig. 2a). An insulated wire (Boston Scientific© Jag-
wire™0.035 450 cm; Boston Scientific, Natick, MA, USA) is then
passed through the 19-G needle using fluoroscopy to monitor
placement of the wire tip into an intra-hepatic duct. After removal
of the 19-G needle, a wire-guided cystotome (Cook Medical©
Cystotome 10 Fr 165 cm with inner catheter removed) is passed
over the wire and using pulsed diathermy (ERBE™ APC2; ERBE
Medical UK, Leeds, UK) a choledocho-duodenostomy is per-
formed (Fig. 2b). Ultrasound imaging is usually sub-optimal at
Figure 1 Dilated common bile duct (CBD) on endoscopic ultra-
sonography (EUS)
(a)
(c)
(b)
Figure 2 (a) Contrast injection. (b) Cystotome over guidewire (c). Stent in situ
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this stage, and therefore fluoroscopy is used to observe the
progress of the cystotome. As soon as the cystotome has clearly
entered the duct it can be removed leaving the wire in place.
A stent is then passed over the wire and positioned across the CDS
(Fig. 2c).
The patient received 200 mg of ciprofloxacin given orally
pre- and post-procedure as for a standard ERBD.
In all patients so far the procedure has been performed in
continuity with the previously attempted ERBD. It is usually
necessary to give additional sedation and analgesia as the proce-
dure time can be anywhere between 30 and 45 min beyond the
attempted ERBD duration.
All patients were followed up post-procedure with regular
serum bilirubin measurements for a minimum of 10 days
post-procedure.
Results
The patient demographics, indications for EUS-CDS and diag-
noses for each patient are given in Table 1.
The serum levels of bilirubin pre- and post-procedure are
represented graphically in Fig. 3. The procedure was completed
successfully in all patients with decompression of the biliary tree
confirmed by a median drop in bilirubin of 164 (range 73–281)
mmol/l by 10 days.
The serum levels returned to normal (<17 mmol/l) in three
patients and there were no immediate complications. None of our
patients developed cholangitis or symptoms of sepsis. Neutrophil
count at day 10 was within the normal range for all
five patients.
The median follow-up was 184 days with four choledocho-
duodenostomies remaining in situ. One patient (C), who had the
plastic stent placed, suffered from a migrated stent and repre-
sented with jaundice at 571 days post-EUS-CDS (discussed
below). Three patients succumbed to their pancreatic cancer.
Discussion
Evidence is growing that EUS-CDS is a safe alternative to surgery
in those patients with an obstructed biliary tree in whom ERBD is
Table 1 Demographics of patients, indication for endoscopic ultrasound-guided choledoco-duodenostomy (EUS-CDS) and outcomes
Patient Age (years) Gender Diagnosis Stent inserted Operation Outcome
A 52 Female Cancer Metal No Relief of jaundice
B 66 Female Cancer Metal Resection Relief of jaundice
C 52 Male Chronic pancreatitis Plastic Beger's Relief of jaundice. distal migration –
jaundice at 571 days
D 55 Female Cancer Metal Palliative bypass Relief of jaundice
E 68 Male Cancer Metal Palliative bypass Relief of jaundice
Figure 3 Serum bilirubin for each patient pre- and post-endoscopic ultrasound-guided choledoco-duodenostomy (EUS-CDS)
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impossible. This case series adds further weight to support the
consideration of EUS-CDS as a feasible option, certainly within
specialist units.
Technically the procedure is similar to EUS-guided drainage of
a pseudocyst and, as the same equipment is involved, there should
be no added financial burden to those units wishing to offer this
service.
The major advantages of EUS-CDS over PTC include: the
reduced risk of complications associated with PTC (hemor-
rhage, cutaneous fistula formation, cholangitis, peritonitis and
empyema) which have been estimated to be 21–32%.4 An addi-
tional benefit of EUS-CDS is the relative ease of performing
the procedure immediately after a failed attempt at ERBD, thus
reducing the delay in decompression of the biliary tree.
In this cohort of patients both a 10F straight plastic stent and
self-expanding covered metal stent were successfully placed;
however, the sole plastic stent migrated leading to the patient (C)
re-presenting with jaundice where successful ERBD was achieved.
A repeat computed tomography at the time of re-presentation
revealed that the stent had migrated (presumably expelled via the
anus) and that the CBDwas obstructed by distal calculi which had
not been evident previously. As stated, an ERCP and sphinctero-
tomy initially relieved the jaundice and a subsequent cholecystec-
tomy was performed. The histology was consistent with chronic
cholecystitis.
In all, EUS-CDS was performed after at least one failed ERBD
thus a single attempt at a further ERCP was made before the
procedure and when this failed EUS-CDS was performed. The
time taken for EUS-CDS was between 30–45 min which is less
than the time taken for a standard percutaneous transhepatic
cholangiography (30–120 min).
Compared with surgical intervention, EUS-CDS has far lower
rates of mortality andmorbidity, albeit without offering a curative
intervention. Therefore the authors have started using EUS-CDS
as a bridge to surgery, as can be seen in three of the five patients in
the current cohort.
A case series in the USA has explored the possibility of dilating
the choledocho-duodenal fistula created at EUS to apply local
endoluminal therapies (e.g. phototherapy) to tumours within
both the pancreas and the main bile duct.5 It might be that such
trans-fistula endoscopic therapies become an alternative method
of delivering cytotoxic agents topically.
A detailed review of the literature has been conducted pre-
viously by Komaki in 2011 identifying 11 case series.2 Since that
time two further studies have been published.5,6 Combined with
the current cohort there are now reports of 56 individual patients
who have undergone EUS-CDS across the world with 98.2%
(n = 55) achieving successful decompression of the biliary tree.
Complications have been low with a combined complication rate
of 21.4% (n = 12) with patients developing cholangitis (n = 4),
biliary peritonitis (n = 4), perforation (n = 3) and 1 patient with
distal stent migration. This combined complication rate compares
favourably with PTC.
The present study is limited by the small size of the cohort.
Recent small-scale prospective studies have confirmed the safety
and efficacy of EUS-CDS and it would now be appropriate to
consider a randomized trial comparing PTC with EUS-CDS in
patients with repeated failed ERBD.
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